Complications of Implantable Cardioverter Defibrillator and Their Potential Risk Factors in Patients with Hypertrophic Cardiomyopathy

被引:0
|
作者
Goudarzi, Mohammad Taghi Hedayati [1 ]
Moradi, Maryam [2 ]
Abrotan, Saeed [1 ]
Saravi, Mehrdad [2 ]
Shirafkan, Hoda [3 ]
Irilouzadian, Rana [4 ]
Omran, Hossein Salehi [1 ]
机构
[1] Babol Univ Med Sci, Rohani Hosp, Sch Med, Dept Cardiol, Babol, Iran
[2] Babol Univ Med Sci, Fac Med, Dept Cardiol, Babol, Iran
[3] Babol Univ Med Sci, Hlth Res Inst, Social Determinants Hlth Res Ctr, Babol, Iran
[4] Iran Univ Med Sci, Burn Res Ctr, Tehran, Iran
关键词
SUDDEN-DEATH; TASK-FORCE; THERAPY; POPULATION; PREVENTION; EFFICACY; OUTCOMES; SOCIETY;
D O I
10.1155/2023/4552100
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. Hypertrophic cardiomyopathy (HCM) has different complications such as cardiac arrhythmia and sudden cardiac death (SCD). Insertion of an implantable cardioverter defibrillator (ICD) is recommended for HCM patients who are at high risk of SCD and malignant arrhythmias, despite having their own potential complications. Hypothesis. We aimed to investigate the prevalence of different complications of ICD insertion and the impact of the potential influential baseline characteristics in a one-year follow-up period. Methods. This was a retrospective study with a total of 71 HCM patients with ICD insertion. We evaluated the prevalence of different complications of ICD implantation and the impact of baseline characteristics on the occurrence of ICD complications using multivariate regression analysis in three 4-month periods. Results. In a one-year follow-up, 13 patients (18.3%) experienced at least one of the complications including pneumothorax, lead failure, ICD infection, inappropriate shocks, perforation, and upper limb deep vein thrombosis (DVT) with no mortality. Inappropriate shocks were reported as the most common (11.3%) complication during this period, with a gradual increase in the second (4.2%) and third (5.6%) follow-up sessions. Among all of the baseline characteristics that were investigated in this study, a positive history of hypertension was the only risk factor with significant impact on the occurrence of complications (P = 0.01). Conclusion. We demonstrated the occurrence of complications during a one-year follow-up as 18.3% in HCM patients with ICD insertion. A positive history of hypertension was the only baseline characteristic affecting the occurrence of complications, and inappropriate shocks were the most common complication.
引用
收藏
页数:7
相关论文
共 50 条
  • [21] Cardioverter-defibrillator implantation in high-risk patients with hypertrophic cardiomyopathy
    Almquist, AK
    Montgomery, JV
    Haas, TS
    Maron, BJ
    HEART RHYTHM, 2005, 2 (08) : 814 - 819
  • [22] Implantable Cardioverter-Defibrillator in PatientsWith Hypertrophic Cardiomyopathy: Efficacy and Complications of the Therapy in Long-Term Follow-up
    Syska, Pawel
    Przybylski, Andrzej
    Chojnowska, Lidia
    Lewandowski, Michal
    Sterlinski, Maciej
    Maciag, Aleksander
    Gepner, Katarzyna
    Pytkowski, Mariusz
    Kowalik, Ilona
    Maczynska-Mazuruk, Renata
    Ruzyllo, Witold
    Szwed, Hanna
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2010, 21 (08) : 883 - 889
  • [23] Risk and predictors of mortality after implantable cardioverter-defibrillator implantation in patients with sarcoid cardiomyopathy
    Higgins, Angela Y.
    Annapureddy, Amarnath R.
    Wang, Yongfei
    Minges, Karl E.
    Bellumkonda, Lavanya
    Lampert, Rachel
    Rosenfeld, Lynda E.
    Jacoby, Daniel L.
    Curtis, Jeptha P.
    Miller, Edward J.
    Freeman, James, V
    AMERICAN HEART JOURNAL, 2022, 246 : 21 - 31
  • [24] The Implantable cardioverter-defibrillator and hypertrophic cardiomyopathy.: Experience at three centers
    Marin, Francisco
    Gimeno, Juan R.
    Paya, Eduardo
    Garcia-Alberola, Arcadio
    Perez-Alvarez, Luisa
    Fernandez, Xusto
    de la Morena, Gonzalo
    Sogorb, Francisco
    Castro-Beiras, Alfonso
    Valdes, Mariano
    Martinez, Juan G.
    Monserrat, Lorenzo
    REVISTA ESPANOLA DE CARDIOLOGIA, 2006, 59 (06): : 537 - 544
  • [25] A Family History of Sudden Death Should Not Be a Primary Indication for an Implantable Cardioverter Defibrillator in Hypertrophic Cardiomyopathy
    Watkinson, Oliver T.
    Elliott, Perry M.
    CANADIAN JOURNAL OF CARDIOLOGY, 2015, 31 (11) : 1407 - 1409
  • [26] Family History of Sudden Death Should Be a Primary Indication for Implantable Cardioverter Defibrillator in Hypertrophic Cardiomyopathy
    Maron, Martin S.
    CANADIAN JOURNAL OF CARDIOLOGY, 2015, 31 (11) : 1402 - 1406
  • [27] Long-Term Performance of Right Ventricular Implantable Cardioverter-Defibrillator Leads in Arrhythmogenic Right Ventricular Cardiomyopathy and Hypertrophic Cardiomyopathy
    Sagawa, Yuichiro
    Nagata, Yasutoshi
    Yamaguchi, Tetsuo
    Mitsui, Kentaro
    Nagamine, Tatsuhiro
    Yamaguchi, Junji
    Hijikata, Sadahiro
    Watanabe, Keita
    Masuda, Ryo
    Miyazaki, Ryoichi
    Kaneko, Masakazu
    Miwa, Naoyuki
    Sekigawa, Masahiro
    Hara, Nobuhiro
    Nozato, Toshihiro
    Ashikaga, Takashi
    Goya, Masahiko
    Sasano, Tetsuo
    Hirao, Kenzo
    INTERNATIONAL HEART JOURNAL, 2020, 61 (01) : 39 - 45
  • [28] Performance of the PRIMaCY sudden death risk prediction model for childhood hypertrophic cardiomyopathy: implications for implantable cardioverter-defibrillator decision-making
    Norrish, Gabrielle
    Protonotarios, Alexandros
    Stec, Maria
    Boleti, Olga
    Field, Ella
    Cervi, Elena
    Elliott, Perry M.
    Kaski, Juan P.
    EUROPACE, 2023, 25 (11):
  • [29] Implantable cardioverter-defibrillators in hypertrophic cardiomyopathy: Patient outcomes, rate of appropriate and inappropriate interventions, and complications
    Vriesendorp, Pieter A.
    Schinkel, Arend F. L.
    Van Cleemput, Johan
    Willems, Rik
    Jordaens, Luc J. L. M.
    Theuns, Dominic A. M. J.
    van Slegtenhorst, Marjon A.
    de Ravel, Thomy J.
    ten Cate, Folkert J.
    Michels, Michelle
    AMERICAN HEART JOURNAL, 2013, 166 (03) : 496 - 502
  • [30] Utilization and Outcomes of Primary Prevention Implantable Cardioverter-Defibrillators in Patients With Hypertrophic Cardiomyopathy
    Goldstein, Sarah A.
    Kennedy, Kevin F.
    Friedman, Daniel J.
    Al-Khatib, Sana M.
    Wang, Andrew
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2023, 12 (16):